默克公司（Merck & Co.）公布最近一个季度营收增长，显示出Keytruda和Winrevair等药物以及其动物保健业务的强劲表现。
Merck MRK -0.63%decrease; down pointing triangle & Co. reported higher revenue in the latest quarter, pointing to strength for drugs such as Keytruda and Winrevair as well as its animal health business.
第三季度业绩超出华尔街预期，并促使该公司上调了全年利润和销售预测。
The third-quarter results topped Wall Street’s expectations, and prompted the company to bump up both its profit and sales forecasts for the year.